Patents by Inventor Robert Lathrop
Robert Lathrop has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11974889Abstract: An apparatus for supporting a medical device on a patient includes a mounting structure configured to be fitted onto the patient to encircle at least a portion of a body part of the patient. The mounting structure includes an inner layer and an outer layer that define a confinement. A jamming material is contained within the confinement. The jamming material is configured to flow within the confinement to conform to the shape of the body part of the patient onto which the mounting structure is fitted. The mass of jamming material is configured to harden and become rigid in its conformed shape in response to a vacuum being formed in the confinement.Type: GrantFiled: November 7, 2016Date of Patent: May 7, 2024Assignee: VANDERBILT UNIVERSITYInventors: Patrick Wellborn, Robert J. Webster, III, Ray Lathrop, Richard J. Hendrick
-
Publication number: 20240085309Abstract: The application is directed to methods and devices for estimating corrosion of a material. One of the methods includes obtaining data regarding corrosion. The data is obtained from various sources, such as but not limited to sensors and observational data. The data is then trained to provide for a more complete data set. The trained data is then used to estimate the expected amount of corrosion for a given situation.Type: ApplicationFiled: September 13, 2022Publication date: March 14, 2024Inventors: Richard Joel Thompson, Tyler Benjamin Smith, Nam Hoang Nguyen, Jason Robert Lathrop, Kristen Smith Williams, Hsien-Lin Huang, Wilbur Harrison Barwick
-
Publication number: 20220331261Abstract: A hydrophobic topical skin composition is disclosed. The composition includes greater than 50% w/w of the composition of a continuous hydrophobic carrier, 5-24% w/w of one or more volatile silicone fluids, and 0.1 to 5% w/w of the composition of a plurality of taxane nanoparticles, wherein the mean particle size (number) of the taxane nanoparticles is from 0.1 microns to 1.5 microns, and wherein the taxane nanoparticles are crystalline nanoparticles or a combination of amorphous and crystalline nanoparticles.Type: ApplicationFiled: March 17, 2022Publication date: October 20, 2022Inventors: Keith JOHNSON, Robert LATHROP, Meidong YANG, Holly MAULHARDT, Roland FRANKE
-
Patent number: 11331278Abstract: A hydrophobic topical skin composition is disclosed. The composition includes greater than 50% w/w of the composition of a continuous hydrophobic carrier, 5-24% w/w of one or more volatile silicone fluids, and 0.1 to 5% w/w of the composition of a plurality of taxane nanoparticles, wherein the mean particle size (number) of the taxane nanoparticles is from 0.1 microns to 1.5 microns, and wherein the taxane nanoparticles are crystalline nanoparticles or a combination of amorphous and crystalline nanoparticles.Type: GrantFiled: December 4, 2020Date of Patent: May 17, 2022Assignee: DFB SORIA, LLCInventors: Keith Johnson, Robert Lathrop, Meidong Yang, Holly Maulhardt, Roland Franke
-
Publication number: 20210369326Abstract: An electrosurgical wand is disclosed for treating a plurality of tissues at a variety of tissue locations. The electrosurgical wand includes a handle on a proximal end and an elongate shaft with a combination active electrode at the distal end. The combination active electrode includes with a blade and screen portion; the blade portion extending along and laterally from the wand longitudinal axis, forming a dissecting tip. The screen portion extends from the blade portion at an obtuse angle and has at least one aspiration aperture through it. The wand also includes a second and third electrode, proximally spaced from the combination active electrode. The second electrode spans a portion of an outside surface of the wand adjacent the blade portion, while the third electrode spans a portion of the outside surface of the wand opposite the second electrode.Type: ApplicationFiled: August 4, 2021Publication date: December 2, 2021Inventors: Jean Woloszko, Jonathan Gaspredes, Douglas G. Evans, Robert Lathrop, Brendan Smith, David Turner, Christopher J. Aholt, Troy S. Hemme
-
Patent number: 11116569Abstract: An electrosurgical wand is disclosed for treating a plurality of tissues at a variety of tissue locations. The electrosurgical wand includes a handle on a proximal end and an elongate shaft with a combination active electrode at the distal end. The combination active electrode includes with a blade and screen portion; the blade portion extending along and laterally from the wand longitudinal axis, forming a dissecting tip. The screen portion extends from the blade portion at an obtuse angle and has at least one aspiration aperture through it. The wand also includes a second and third electrode, proximally spaced from the combination active electrode. The second electrode spans a portion of an outside surface of the wand adjacent the blade portion, while the third electrode spans a portion of the outside surface of the wand opposite the second electrode.Type: GrantFiled: May 16, 2018Date of Patent: September 14, 2021Assignee: Smith & Nephew, Inc.Inventors: Jean Woloszko, Jonathan Gaspredes, Douglas G. Evans, Robert Lathrop, Brendan Smith, David Turner, Christopher J. Aholt, Troy S. Hemme
-
Publication number: 20210169565Abstract: An electrosurgical wand is disclosed for providing a range of tissue treatment modes and for use in a variety of orientations. The electrosurgical wand includes a handle on a proximal end, an elongate shaft and at least three distinct electrodes disposed at a distal end of the wand. The three electrodes include a blade electrode having a length measured parallel to a longitudinal axis of wand, the length running parallel to the wand longitudinal axis for a portion of the length. The blade electrode has a distal portion that curves toward the longitudinal axis at the distal end of the wand. The three electrodes also include a second electrode disposed on a second side of the wand from the blade electrode; and a third electrode disposed between the blade electrode and the second electrode. All the electrodes have a different shape and surface area.Type: ApplicationFiled: May 16, 2018Publication date: June 10, 2021Applicant: Smith & Nephew, Inc.Inventors: Jean Woloszko, Jonathan Gaspredes, Douglas G. Evans, Robert Lathrop, Brendan Smith, David Turner, Christopher J. Aholt, Troy S. Hemme
-
Publication number: 20210106539Abstract: A hydrophobic topical skin composition is disclosed. The composition includes greater than 50% w/w of the composition of a continuous hydrophobic carrier, 5-24% w/w of one or more volatile silicone fluids, and 0.1 to 5% w/w of the composition of a plurality of taxane nanoparticles, wherein the mean particle size (number) of the taxane nanoparticles is from 0.1 microns to 1.5 microns, and wherein the taxane nanoparticles are crystalline nanoparticles or a combination of amorphous and crystalline nanoparticles.Type: ApplicationFiled: December 4, 2020Publication date: April 15, 2021Applicant: DFB Soria, LLCInventors: Keith JOHNSON, Robert LATHROP, Meidong YANG, Holly MAULHARDT, Roland FRANKE
-
Patent number: 10918606Abstract: Disclosed are compositions and methods useful for enhancing the skin penetration of drug nanoparticles. The compositions can be hydrophobic and include a hydrophobic carrier, a volatile silicone fluid, and drug nanoparticles. Also disclosed are methods for inhibiting crystal growth of drug nanoparticles in an aqueous carrier or a hydrophobic carrier. Further, methods to topically treat psoriasis using compositions containing nanoparticles of paclitaxel or other taxanes are disclosed.Type: GrantFiled: September 11, 2019Date of Patent: February 16, 2021Assignee: DFB Soria, LLCInventors: Keith Johnson, Robert Lathrop, Meidong Yang, Holly Maulhardt, Roland Franke
-
Publication number: 20200397500Abstract: An electrosurgical wand is disclosed for treating a plurality of tissues at a variety of tissue locations. The electrosurgical wand includes a handle on a proximal end and an elongate shaft with a combination active electrode at the distal end. The combination active electrode includes with a blade and screen portion; the blade portion extending along and laterally from the wand longitudinal axis, forming a dissecting tip. The screen portion extends from the blade portion at an obtuse angle and has at least one aspiration aperture through it. The wand also includes a second and third electrode, proximally spaced from the combination active electrode. The second electrode spans a portion of an outside surface of the wand adjacent the blade portion, while the third electrode spans a portion of the outside surface of the wand opposite the second electrode.Type: ApplicationFiled: May 16, 2018Publication date: December 24, 2020Applicant: Smith & Nephew, Inc.Inventors: Jean Woloszko, Jonathan Gaspredes, Douglas G. Evans, Robert Lathrop, Brendan Smith, David Turner, Christopher J. Aholt, Troy S. Hemme
-
Publication number: 20200188014Abstract: An electrosurgical wand is disclosed for providing a range of tissue treatment modes and for use in a variety of orientations. The electrosurgical wand includes a handle on a proximal end, an elongate shaft and at least three distinct electrodes disposed at a distal end of the wand. The three electrodes include a blade electrode having a length measured parallel to a longitudinal axis of wand, the length running parallel to the wand longitudinal axis for a portion of the length. The blade electrode has a distal portion that curves toward the longitudinal axis at the distal end of the wand. The three electrodes also include a second electrode disposed on a second side of the wand from the blade electrode; and a third electrode disposed between the blade electrode and the second electrode. All the electrodes have a different shape and surface area.Type: ApplicationFiled: December 13, 2019Publication date: June 18, 2020Applicant: Smith & Nephew, Inc.Inventors: Jean Woloszko, Jonathan Gaspredes, Douglas G. Evans, Robert Lathrop, Brendan Smith, David Turner, Christopher J. Aholt, Troy S. Hemme
-
Publication number: 20200069600Abstract: Disclosed are compositions and methods useful for enhancing the skin penetration of drug nanoparticles. The compositions can be hydrophobic and include a hydrophobic carrier, a volatile silicone fluid, and drug nanoparticles. Also disclosed are methods for inhibiting crystal growth of drug nanoparticles in an aqueous carrier or a hydrophobic carrier. Further, methods to topically treat psoriasis using compositions containing nanoparticles of paclitaxel or other taxanes are disclosed.Type: ApplicationFiled: September 11, 2019Publication date: March 5, 2020Applicant: DFB Soria, LLCInventors: Keith JOHNSON, Robert LATHROP, Meidong YANG, Holly MAULHARDT, Roland FRANKE
-
Publication number: 20200054552Abstract: The invention relates to a medicament containing a compound of general formula (I), where R1=independently, a straight or branched, saturated, singly- or multiply-unsaturated, optionally substituted C11-C21 alkyl, alkylene or alkinyl group, preferably a C11-C15 alkyl, alkylene or alkinyl group, particularly a C11-C13 alkyl, alkylene or alkinyl group, most preferably a C13 alkyl group, R2=independently, a straight or branched C1-C8 alkyl, alkylene or alkinyl group, preferably a C1-C6 alkyl, alkylene or alkinyl group, in particular a C2-C4 alkyl, alkylene or alkinyl group, most preferably a C3 alkyl group, a —[CH2—(CH2)m—O]nH group with n=1 to 10, preferably n=1 to 5, to m=1 to 5, preferably m=1 to 3, a —CH2—[CH—(OH)]p [CH2—R3]-group, where R3=independently H or OH, p=1 to 7, preferably p=1 to 4, a pentose group or a hexose group, as therapeutically active agent, alone or in combination with one or several further pharmaceutical agents as a combination preparation for the treatment of viral skin diseases and/orType: ApplicationFiled: August 19, 2019Publication date: February 20, 2020Inventors: Yunik CHANG, Robert LATHROP, Erwin BOHM, Irene GANDER-MEISTERERNST, Regina GREGER, Johanna HOLLDACK, Ulrich MOEBIUS
-
Patent number: 10449162Abstract: Disclosed are compositions and methods useful for enhancing the skin penetration of drug nanoparticles. The compositions can be hydrophobic and include a hydrophobic carrier, a volatile silicone fluid, and drug nanoparticles. Also disclosed are methods for inhibiting crystal growth of drug nanoparticles in an aqueous carrier or a hydrophobic carrier. Further, methods to topically treat psoriasis using compositions containing nanoparticles of paclitaxel or other taxanes are disclosed.Type: GrantFiled: February 19, 2018Date of Patent: October 22, 2019Assignee: DFB Soria LLCInventors: Keith Johnson, Robert Lathrop, Meidong Yang, Holly Maulhardt, Roland Franke
-
Patent number: 10434059Abstract: The invention relates to a medicament containing a compound of general formula (I), where R1=independently, a straight or branched, saturated, singly- or multiply-unsaturated, optionally substituted C11-C21 alkyl, alkylene or alkinyl group, preferably a C11-C15 alkyl, alkylene or alkinyl group, particularly a C11-C13 alkyl, alkylene or alkinyl group, most preferably a C13 alkyl group, R2=independently, a straight or branched C1-C8 alkyl, alkylene or alkinyl group, preferably a C1-C6 alkyl, alkylene or alkinyl group, in particular a C2-C4 alkyl, alkylene or alkinyl group, most preferably a C3 alkyl group, a —[CH2—(CH2)m-O]nH group with n=1 to 10, preferably n=1 to 5, to m=1 to 5, preferably m=1 to 3, a —CH2—[CH—(OH)]p[CH2—R3]— group, where R3=independently H or OH, p=1 to 7, preferably p=1 to 4, a pentose group or a hexose group, as therapeutically active agent, alone or in combination with one or several further pharmaceutical agents as a combination preparation for the treatment of viral skin diseases and/orType: GrantFiled: August 18, 2017Date of Patent: October 8, 2019Assignee: Fougera Pharmaceuticals Inc.Inventors: Yunik Chang, Robert Lathrop, Erwin Böhm, Irene Gander-Meisterernst, Regina Greger, Johanna Holldack, Ulrich Moebius
-
Patent number: 10111956Abstract: The present disclosure generally relates to pharmaceutical corticosteroid compositions, and methods of making the same.Type: GrantFiled: June 3, 2014Date of Patent: October 30, 2018Assignee: Tolmar, Inc.Inventors: Robert Lathrop, David Wade Osborne
-
Publication number: 20180193254Abstract: The invention relates to a medicament containing a compound of general formula (I), where R1=independently, a straight or branched, saturated, singly- or multiply-unsaturated, optionally substituted C11-C21 alkyl, alkylene or alkinyl group, preferably a C11-C15 alkyl, alkylene or alkinyl group, particularly a C11-C13 alkyl, alkylene or alkinyl group, most preferably a C13 alkyl group, R2=independently, a straight or branched C1-C8 alkyl, alkylene or alkinyl group, preferably a C1-C6 alkyl, alkylene or alkinyl group, in particular a C2-C4 alkyl, alkylene or alkinyl group, most preferably a C3 alkyl group, a —[CH2—(CH2)m-O]nH group with n=1 to 10, preferably n=1 to 5, to m=1 to 5, preferably m=1 to 3, a —CH2—[CH—(OH)]p [CH2—R3]— group, where R3=independently H or OH, p=1 to 7, preferably p=1 to 4, a pentose group or a hexose group, as therapeutically active agent, alone or in combination with one or several further pharmaceutical agents as a combination preparation for the treatment of viral skin diseases and/oType: ApplicationFiled: August 18, 2017Publication date: July 12, 2018Applicant: Fougera Pharmaceuticals Inc.Inventors: Yunik CHANG, Robert LATHROP, Erwin BÖHM, Irene GANDER-MEISTERERNST, Regina GREGER, Johanna HOLLDACK, Ulrich MOEBIUS
-
Publication number: 20180177739Abstract: Disclosed are compositions and methods useful for enhancing the skin penetration of drug nanoparticles. The compositions can be hydrophobic and include a hydrophobic carrier, a volatile silicone fluid, and drug nanoparticles. Also disclosed are methods for inhibiting crystal growth of drug nanoparticles in an aqueous carrier or a hydrophobic carrier. Further, methods to topically treat psoriasis using compositions containing nanoparticles of paclitaxel or other taxanes are disclosed.Type: ApplicationFiled: February 19, 2018Publication date: June 28, 2018Applicant: DFB Soria, LLCInventors: Keith JOHNSON, Robert LATHROP, Meidong YANG, Holly MAULHARDT, Roland FRANKE
-
Patent number: 9770406Abstract: The invention relates to a medicament containing a compound of general formula (I), where R1=independently, a straight or branched, saturated, singly- or multiply-unsaturated, optionally substituted C11-C21 alkyl, alkylene or alkinyl group, preferably a C11-C15 alkyl, alkylene or alkinyl group, particularly a C11-C13 alkyl, alkylene or alkinyl group, most preferably a C13 alkyl group, R2=independently, a straight or branched C1-C8 alkyl, alkylene or alkinyl group, preferably a C1-C6 alkyl, alkylene or alkinyl group, in particular a C2-C4 alkyl, alkylene or alkinyl group, most preferably a C3 alkyl group, a —[CH2—(CH2)m-O]nH group with n=1 to 10, preferably n=1 to 5, to m=1 to 5, preferably m=1 to 3, a —CH2—[CH—(OH)]p[CH2—R3]- group, where R3=independently H or OH, p=1 to 7, preferably p=1 to 4, a pentose group or a hexose group, as therapeutically active agent, alone or in combination with one or several further pharmaceutical agents as a combination preparation for the treatment of viral skin diseases and/orType: GrantFiled: September 21, 2010Date of Patent: September 26, 2017Assignee: Medigene AGInventors: Yunik Chang, Robert Lathrop, Erwin Böhm, Irene Gander-Meisterernst, Regina Greger, Johanna Holldack, Ulrich Moebius
-
Publication number: 20160155086Abstract: A system for managing delivery of cargo comprises a communications module located in a vehicle. The communications module includes a communications component, a navigation component and an electronic interface. One or more processors remote to the communications module execute a management application which is communicatively coupled to the communications module. The communications component receives from the management application information of the delivery of the cargo to a destination. The electronic interface receives information of at least one additional destination. The navigation component provides navigation instructions to the destination and the at least one additional destination. The navigation component provides navigation instructions through the electronic interface. The communications component receives information of an arrival of the vehicle at a location, the location including one or more of the destination and the at least one additional destination.Type: ApplicationFiled: February 9, 2016Publication date: June 2, 2016Inventors: Max L. Fuller, Ken Crane, Scott Davison, Robert Lathrop